Phenotypic Characteristics of Superlean Individuals Including Gut Microbiome
NCT ID: NCT05804929
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2023-04-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How do Super Lean Subjects Keep Resistant to Body Weight Gain?
NCT03221322
Impact of Health Lifestyle on Body Weight
NCT05608226
Effect of Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone Responses in Obese and Healthy Weight Subjects
NCT03860623
Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
NCT05729269
Genetics of Obesity in Chinese Youngs
NCT01084967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
21.5≤BMI\<25, age between 25-40 years old, 200subjects.
Observation without intervention
Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.
Superlean
BMI≤18.5, age between 25-40 years old, 200 subjects.
Observation without intervention
Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation without intervention
Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 25-40 years old
Exclusion Criteria
* Recent weight loss due to various disease causes
* Being treated for weight loss
* Having an infectious disease
* Pregnant and lactating women
* People with blood sickness, pathological hypo- or hypertension
* People suffering from claustrophobia
* No metal implants in the body
* Use of antibiotics, probiotics, oral laxatives, etc. within 8 weeks
25 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John R. Speakman
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen Institute of Advanced Technology,
Shenzhen, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIAT-IRB-221115-H0628
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.